Decreased incidence of lupus nephritis in northern Norway is linked to increased use of antihypertensive and anticoagulant therapy

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Gro Østli EilertsenJ Nossent

Abstract

Lupus nephritis (LN) remains a severe complication in systemic lupus erythematosus (SLE). Over the last decade, antiphospholipid antibodies have become a part of SLE classification criteria, and awareness of cardiovascular morbidity and its risk factors in SLE has increased. This study investigated the potential effect of these alterations on the presentation and severity of LN. This is an observational study of two subsequent SLE inception cohorts based on 1982 American College of Rheumatology (acr) classification criteria (82acr; n=87, enrolled 1978-95) and the updated version in 1997 (97acr: n=62, enrolled 1996-2006). Annual incidence rates (AIR), point prevalence, clinical and histological features, and outcome of LN (defined as proteinuria with urinary casts and/or haematuria) were compared between both cohorts. Between 1978 and 2006, the AIR for LN decreased from 0.7 to 0.45/100 000, while LN prevalence rose from 7 to 14/100 000. The relative risk reduction in the 97acr for early- and late-onset LN (> 3 months after SLE diagnosis) was 39% and 42%, respectively. Patients developing LN in the 97acr cohort (97LN+; n=11) had similar demographics, more often low avidity anti-dsDNA antibodies (Ab) and/or anti-cardiolipin Ab at ...Continue Reading

References

Feb 16, 1989·The New England Journal of Medicine·A PierucciC Patrono
Sep 1, 1983·The American Journal of Medicine·H A AustinJ E Balow
Nov 1, 1982·Arthritis and Rheumatism·E M TanR J Winchester
Apr 1, 1994·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·K IsekiK Fukiyama
Mar 14, 1998·Circulation·S HusainA A Quyyumi
May 8, 1998·The New England Journal of Medicine·B H Hahn
Jun 30, 1998·Journal of the American Society of Nephrology : JASN·S TomasoniG Remuzzi
Apr 24, 1999·Journal of the American Society of Nephrology : JASN·J S Cameron
Jan 24, 2002·The Journal of Experimental Medicine·V Michael HolersJane E Salmon
Jun 25, 2002·The American Journal of Medicine·Victoria A SeligmanLindsey A Criswell
Sep 5, 2003·The Journal of Pharmacology and Experimental Therapeutics·Guillermo Pérez De LemaDetlef Schlöndorff
Oct 17, 2003·The New England Journal of Medicine·Melissa R ArbuckleJohn B Harley
Dec 6, 2003·Hypertension·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jan 9, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Gabriella MoroniClaudio Ponticelli
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Jan J WeeningMichio Nagata
Feb 12, 2004·Kidney International·Deijanira Alves De AlbuquerqueRam Raj Singh
Apr 5, 2005·Autoimmunity·Piersandro RiboldiPier Luigi Meroni
Jul 6, 2006·Kidney International·C GrootscholtenUNKNOWN Dutch Working Party on Systemic Lupus Erythematosus
Sep 2, 2006·Arthritis and Rheumatism·Mumtaz PatelDeborah P M Symmons
Jun 7, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Angelique L RopsJo H Berden
Aug 29, 2009·European Journal of Internal Medicine·C MolinoC Longhini

❮ Previous
Next ❯

Citations

Jan 15, 2013·Rheumatology International·Kuo-Wei YehJing-Long Huang
Dec 30, 2014·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Aladdin J MohammadMårten Segelmark
May 3, 2016·The Journal of Rheumatology·Marie-Louise F HermansenSøren Jacobsen
Aug 2, 2017·International Journal of Rheumatic Diseases·Farshad GhazanfariJohannes Nossent

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Related Papers

Critical Care Nursing Clinics of North America
Sharon L Haney
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Hirofumi MakinoKenei Sada
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
Rudolf P Wüthrich
Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine
Barbara Phillips, Shirin Shafazand
© 2021 Meta ULC. All rights reserved